These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Feinglass EJ; Arnett FC; Dorsch CA; Zizic TM; Stevens MB Medicine (Baltimore); 1976 Jul; 55(4):323-39. PubMed ID: 781466 [TBL] [Abstract][Full Text] [Related]
3. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Sergent JS; Lockshin MD; Klempner MS; Lipsky BA Am J Med; 1975 May; 58(5):644-54. PubMed ID: 1130420 [TBL] [Abstract][Full Text] [Related]
4. The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus. Gaylis NB; Altman RD; Ostrov S; Quencer R J Rheumatol; 1982; 9(6):850-4. PubMed ID: 7161775 [TBL] [Abstract][Full Text] [Related]
5. Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Baker M; Hadler NM; Whitaker JN; Dunner DL; Gerwin RD; Decker JL Semin Arthritis Rheum; 1973; 3(2):111-26. PubMed ID: 4584527 [No Abstract] [Full Text] [Related]
11. [Headache in the pathology of small cerebral blood vessels: study of patients with systemic lupus erythematosus]. Atkinson RA; Appenzeller O Minerva Med; 1976 Jun; 67(28):1854-7. PubMed ID: 934532 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of systemic lupus erythematosus and of pseudo-le-syndrome]. Ricken D; Flenker I Dtsch Med Wochenschr; 1978 Nov; 103(46):1821-3. PubMed ID: 710299 [No Abstract] [Full Text] [Related]
13. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328 [TBL] [Abstract][Full Text] [Related]
14. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone. Barnett EV; Dornfeld L; Lee DB; Liebling MR J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523 [TBL] [Abstract][Full Text] [Related]
15. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. Bresnihan B; Hohmeister R; Cutting J; Travers RL; Waldburger M; Black C; Jones T; Hughes GR Ann Rheum Dis; 1979 Aug; 38(4):301-6. PubMed ID: 496443 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic drug treatment of lupus nephritis. Donadio JV; Holley KE; Ilstrup DM Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Kasitanon N; Louthrenoo W; Piyasirisilp S; Sukitawu W; Wichainun R Asian Pac J Allergy Immunol; 2002 Sep; 20(3):179-85. PubMed ID: 12587842 [TBL] [Abstract][Full Text] [Related]
18. Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with systemic lupus erythematosus (SLE) and lupus nephritis. Zar T; Samson W; Palmisano J Nephrol Dial Transplant; 2007 Aug; 22(8):2400-1. PubMed ID: 17517793 [No Abstract] [Full Text] [Related]
19. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616 [TBL] [Abstract][Full Text] [Related]
20. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]